Peripheral blood monocyte hepcidin in patients with multiple myeloma is associated with anemia of chronic disease.
10.7534/j.issn.1009-2137.2013.02.030
- Author:
Xiao HAN
1
;
Dao-Bin ZHOU
;
Ming-Hui DUAN
;
Xuan WANG
;
Jie-Ping ZHANG
;
Yong-Qiang ZHAO
;
Ti SHEN
;
Yong-Ji WU
Author Information
1. Department of Hematology, Chinese Academy of Medical Sciences, Beijing, China.
- Publication Type:Journal Article
- MeSH:
Adult;
Aged;
Anemia;
etiology;
Case-Control Studies;
Chronic Disease;
Female;
Ferritins;
blood;
Hepcidins;
blood;
Humans;
Interleukin-6;
blood;
Leukocytes, Mononuclear;
metabolism;
Male;
Middle Aged;
Monocytes;
metabolism;
Multiple Myeloma;
blood;
complications;
Tumor Necrosis Factor-alpha;
blood
- From:
Journal of Experimental Hematology
2013;21(2):403-409
- CountryChina
- Language:Chinese
-
Abstract:
Disorders of iron utilization caused by abnormal elevation of hepcidin levels are the main mechanism of anemia of chronic disease. Hepcidin is mainly produced by the liver. Recently it has been found that monocytes are another source of hepcidin. The increased hepcidin in serum and urine of multiple myeloma patients may be one cause of anemia of chronic disease (ACD). However it is unclear whether the peripheral blood monocyte hepcidin is involved in the pathogenesis of anemia of chronic disease. This study was purposed to investigate the role of monocyte hepcidin in multiple myeloma patients with anemia of chronic disease. The clinical data and peripheral venous blood of multiple myeloma patients were collected.Serum concentration of IL-6 and TNF-α was detected by ELISA. Peripheral blood monocytes were isolated by CD14(+) magnetic beads. Hepcidin, IL-6 and TNF-α mRNA of monocytes were detected by real time quantitative PCR. The results showed that the expression level of monocyte hepcidin mRNA in myeloma patients was higher than that in normal controls. In untreated patients, the expression level of monocyte hepcidin mRNA was negatively correlated with hemoglobin, and positively correlated with serum ferritin and IL-6 levels, but unrelated with TNF-α levels.It is concluded that the increased monocyte hepcidin levels in multiple myeloma patients may play an etiologic role in ACD.
